285 related articles for article (PubMed ID: 24633743)
1. Novel therapeutics in acute myeloid leukemia.
Sweet K; Lancet JE
Curr Hematol Malig Rep; 2014 Jun; 9(2):109-17. PubMed ID: 24633743
[TBL] [Abstract][Full Text] [Related]
2. Is targeted therapy feasible in acute myelogenous leukemia?
Konig H; Levis M
Curr Hematol Malig Rep; 2014 Jun; 9(2):118-27. PubMed ID: 24599573
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia: current progress and future directions.
Kantarjian H; Kadia T; DiNardo C; Daver N; Borthakur G; Jabbour E; Garcia-Manero G; Konopleva M; Ravandi F
Blood Cancer J; 2021 Feb; 11(2):41. PubMed ID: 33619261
[TBL] [Abstract][Full Text] [Related]
4. Novel drug targets in acute leukemia.
Stock W
Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809
[No Abstract] [Full Text] [Related]
5. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
Naqvi K; Konopleva M; Ravandi F
Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
[TBL] [Abstract][Full Text] [Related]
6. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
7. Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges.
Ling Y; Zhang Z; Zhang H; Huang Z
Curr Pharm Des; 2017 Nov; 23(29):4303-4310. PubMed ID: 28671056
[TBL] [Abstract][Full Text] [Related]
8. From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia.
Yilmaz M; Daver N
Drugs; 2019 Jul; 79(11):1177-1186. PubMed ID: 31222627
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies in hematology and their impact on patient care: chronic and acute myeloid leukemia.
Jabbour E; Cortes J; Ravandi F; O'Brien S; Kantarjian H
Semin Hematol; 2013 Oct; 50(4):271-83. PubMed ID: 24246694
[TBL] [Abstract][Full Text] [Related]
10. Developmental therapeutics in acute myelogenous leukemia: are there any new effective cytotoxic chemotherapeutic agents out there?
Mims A; Stuart RK
Curr Hematol Malig Rep; 2013 Jun; 8(2):156-62. PubMed ID: 23640069
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations in acute myeloid leukemias.
Mehdipour P; Santoro F; Minucci S
FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
[TBL] [Abstract][Full Text] [Related]
12. [Progress in molecularly targeted therapies for acute myeloid leukemia].
Tomita A
Rinsho Ketsueki; 2015 Feb; 56(2):130-8. PubMed ID: 25765792
[TBL] [Abstract][Full Text] [Related]
13. New drugs in acute myeloid leukemia.
Kadia TM; Ravandi F; Cortes J; Kantarjian H
Ann Oncol; 2016 May; 27(5):770-8. PubMed ID: 26802152
[TBL] [Abstract][Full Text] [Related]
14. FLT3 inhibitors in AML: are we there yet?
Sudhindra A; Smith CC
Curr Hematol Malig Rep; 2014 Jun; 9(2):174-85. PubMed ID: 24682858
[TBL] [Abstract][Full Text] [Related]
15. Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia).
Lin M; Chen B
Drug Des Devel Ther; 2018; 12():1009-1017. PubMed ID: 29750014
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
Fernandez S; Desplat V; Villacreces A; Guitart AV; Milpied N; Pigneux A; Vigon I; Pasquet JM; Dumas PY
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336846
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia: advancing clinical trials and promising therapeutics.
Daver N; Cortes J; Kantarjian H; Ravandi F
Expert Rev Hematol; 2016 May; 9(5):433-45. PubMed ID: 26910051
[TBL] [Abstract][Full Text] [Related]
18. The Future of Targeting FLT3 Activation in AML.
Leick MB; Levis MJ
Curr Hematol Malig Rep; 2017 Jun; 12(3):153-167. PubMed ID: 28421420
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?
Megías-Vericat JE; Ballesta-López O; Barragán E; Martínez-Cuadrón D; Montesinos P
Blood Rev; 2020 Nov; 44():100675. PubMed ID: 32147087
[TBL] [Abstract][Full Text] [Related]
20. Closing in on targeted therapy for acute myeloid leukaemia.
The Lancet Haematology
Lancet Haematol; 2019 Jan; 6(1):e1. PubMed ID: 30612709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
